Temat: "breast neoplasms" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis.
Autorzy:: Bahrin NWS; Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB) Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE1410, Negara Brunei Darussalam.
Matusin SNI; Halalan Thayyiban Research Centre, Universiti Islam Sultan Sharif Ali, Jalan Tutong, Sinaut, TB1741, Negara Brunei Darussalam.
Mustapa A; Halalan Thayyiban Research Centre, Universiti Islam Sultan Sharif Ali, Jalan Tutong, Sinaut, TB1741, Negara Brunei Darussalam.
Huat LZ; Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB) Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE1410, Negara Brunei Darussalam.
Perera S; Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
Hamid MRWHA; Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB) Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE1410, Negara Brunei Darussalam. .; Pokaż więcej
Źródło:: Systematic reviews [Syst Rev] 2024 Apr 04; Vol. 13 (1), pp. 100. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Bridged-Ring Compounds*
Humans ; Female ; Ki-67 Antigen/metabolism ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Taxoids/therapeutic use ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Receptors, Estrogen/therapeutic use ; Class I Phosphatidylinositol 3-Kinases/therapeutic use ; Genetic Variation ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Correlation of shear-wave elastography stiffness and apparent diffusion coefficient values with tumor characteristics in breast cancer.
Autorzy:: Kwon MR; Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Youn I; Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Ko ES; Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea. .
Choi SH; Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Queen's U Clinic, Seoul, South Korea.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 26; Vol. 14 (1), pp. 7180. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Elasticity Imaging Techniques*/methods
Mammary Neoplasms, Animal*
Triple Negative Breast Neoplasms*
Humans ; Animals ; Female ; Breast/pathology ; Ultrasonography, Mammary/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients.
Autorzy:: Kim EY; Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee KH; Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Yun JS; Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Park YL; Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Park CH; Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Jang SY; Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Ryu JM; Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Lee SK; Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Chae BJ; Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Lee JE; Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Kim SW; Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Nam SJ; Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Yu JH; Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea. .; Pokaż więcej
Źródło:: BMC women's health [BMC Womens Health] 2024 Mar 20; Vol. 24 (1), pp. 187. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Calcinosis*/diagnostic imaging
Calcinosis*/drug therapy
Calcinosis*/etiology
Humans ; Female ; Neoadjuvant Therapy/adverse effects ; Prognosis ; Breast/pathology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chemotherapy, Adjuvant ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women.
Autorzy:: Al-Moghrabi N; Cancer Epigenetics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Al-Showimi M; Cancer Epigenetics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Alqahtani A; Cancer Epigenetics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Almalik O; Cancer Epigenetics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Alhusaini H; Cancer Epigenetics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Almalki G; Cancer Epigenetics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Saad A; Cancer Epigenetics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Alsunayi E; Cancer Epigenetics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 07; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Triple Negative Breast Neoplasms*/epidemiology
Triple Negative Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Ovarian Neoplasms*/epidemiology
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Female ; Humans ; Saudi Arabia/epidemiology ; Promoter Regions, Genetic ; BRCA1 Protein/genetics ; BRCA1 Protein/metabolism ; DNA Methylation ; Risk Factors ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Genetic Predisposition to Disease ; DNA Modification Methylases/genetics ; DNA Modification Methylases/metabolism ; Tumor Suppressor Proteins/genetics ; Tumor Suppressor Proteins/metabolism ; DNA Repair Enzymes/genetics ; DNA Repair Enzymes/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer.
Autorzy:: Salvanou EA; Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research 'Demokritos', 15341 Athens, Greece.
Kolokithas-Ntoukas A; Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Prokopiou D; Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, 15771 Athens, Greece.
Theodosiou M; Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, 15771 Athens, Greece.
Efthimiadou E; Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, 15771 Athens, Greece.
Koźmiński P; Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Dorodna 16 Str., 03-195 Warsaw, Poland.
Xanthopoulos S; Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research 'Demokritos', 15341 Athens, Greece.
Avgoustakis K; Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Bouziotis P; Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research 'Demokritos', 15341 Athens, Greece.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Feb 27; Vol. 29 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: Triple Negative Breast Neoplasms*
Nanoparticles*
Breast Neoplasms*/metabolism
Humans ; Animals ; Mice ; Female ; Bevacizumab ; Tissue Distribution ; Doxorubicin ; Magnetic Iron Oxide Nanoparticles ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy.
Autorzy:: Arqueros C; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Gallardo A; Department of Pathology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Morphological Sciences, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Vidal S; Inflammatory Diseases, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Osuna-Gómez R; Inflammatory Diseases, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Tibau A; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Lidia Bell O; Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Ramón Y Cajal T; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Lerma E; Department of Pathology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Morphological Sciences, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Lobato-Delgado B; Unitat de Genòmica de Malalties Complexes, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Salazar J; Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Barnadas A; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.; Centro de Investigación Biomedica en Red Cancer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; Neoadjuvant Therapy/adverse effects ; Clinical Relevance ; Retrospective Studies ; Biomarkers, Tumor/analysis ; Lymphocytes, Tumor-Infiltrating ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Comparative analysis of breast cancer characteristics in young premenopausal and postmenopausal women in Ghana.
Autorzy:: Bosompem K; Directorate of Surgery, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Yorke J; Department of Surgery, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Buckman TA; Department of Medical Laboratory Science, KAAF University College, Buduburam, Ghana.
Brenu SG; Directorate of Surgery, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Nyantakyi M; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Aitpillah FS; Directorate of Surgery, Komfo Anokye Teaching Hospital, Kumasi, Ghana.; Department of Surgery, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Kyei I; Department of Surgery, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Adinku MO; Directorate of Surgery, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Yorke DA; Directorate of Surgery, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Obirikorang C; Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Acheampong E; Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. .; Leicester Cancer Research Centre, Department of Genetic and Genome Biology, University of Leicester, Leicester, LE1 7RH, UK. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 01; Vol. 14 (1), pp. 2704. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/epidemiology
Breast Neoplasms*/therapy
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; Postmenopause ; Ghana/epidemiology ; Cross-Sectional Studies ; Prospective Studies ; Receptor, ErbB-2/analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience.
Autorzy:: Piedra-Delgado L; Universidad Científica del Sur, Lima, Perú.
Chambergo-Michilot D; Universidad Científica del Sur, Lima, Perú.
Morante Z; Departamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Fairen C; Boston Medical Center, Boston, Massachusetts, United States of America.
Jerves-Coello F; Morristown Medical Center, Morristown, New Jersey, United States of America.
Luque-Benavides R; Universidad Científica del Sur, Lima, Perú.
Casas F; Universidad Peruana Cayetano Heredia, Lima, Peru.
Bustamante E; Universidad Peruana de Ciencias Aplicadas, Lima, Peru.
Razuri-Bustamante C; Universidad Ricardo Palma, Lima, Peru.
Torres-Roman JS; Universidad Científica del Sur, Lima, Perú.
Fuentes H; Departamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Gomez H; Departamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Narvaez-Rojas A; Department of Surgical Oncology, Miller School of Medicine, University Of Miami, Miami, Florida, United States of America.
De la Cruz-Ku G; Universidad Científica del Sur, Lima, Perú.
Araujo J; Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Chorrillos, Lima, Peru.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 01; Vol. 19 (2), pp. e0293833. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Triple Negative Breast Neoplasms*/pathology
Breast Neoplasms*/pathology
Humans ; Female ; Peru/epidemiology ; Neoplasm Staging ; Retrospective Studies ; Neoplasm Recurrence, Local/pathology ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation.
Autorzy:: Wang J; From the Department of Pathology (Wang, Aung, Resetkova, Sahin, Huo, Ding), The University of Texas MD Anderson Cancer Center, Houston.
Peng Y; the Department of Pathology, The University of Texas Southwestern Medical Center, Dallas (Peng).
Sun H; the Department of Pathology and Laboratory Medicine, The University of Texas McGovern Medical School, Houston (Sun).
Aung PP; From the Department of Pathology (Wang, Aung, Resetkova, Sahin, Huo, Ding), The University of Texas MD Anderson Cancer Center, Houston.
Resetkova E; From the Department of Pathology (Wang, Aung, Resetkova, Sahin, Huo, Ding), The University of Texas MD Anderson Cancer Center, Houston.
Yam C; the Department of Breast Medical Oncology (Yam), The University of Texas MD Anderson Cancer Center, Houston.
Sahin AA; From the Department of Pathology (Wang, Aung, Resetkova, Sahin, Huo, Ding), The University of Texas MD Anderson Cancer Center, Houston.
Huo L; From the Department of Pathology (Wang, Aung, Resetkova, Sahin, Huo, Ding), The University of Texas MD Anderson Cancer Center, Houston.
Ding Q; From the Department of Pathology (Wang, Aung, Resetkova, Sahin, Huo, Ding), The University of Texas MD Anderson Cancer Center, Houston.; Pokaż więcej
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Feb 01; Vol. 148 (2), pp. 200-205.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; Biomarkers, Tumor/metabolism ; Receptors, Estrogen/metabolism ; Breast/pathology ; GATA3 Transcription Factor/metabolism ; Repressor Proteins

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Machine learning analysis of breast ultrasound to classify triple negative and HER2+ breast cancer subtypes.
Autorzy:: Ferre R; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Elst J; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Senthilnathan S; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Lagree A; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Tabbarah S; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Lu FI; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Sadeghi-Naini A; Department of Electrical Engineering and Computer Science, York University, Toronto, ON, Canada.
Tran WT; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Temerty Centre for AI Research and Education, University of Toronto, ON, Canada.
Curpen B; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.; Pokaż więcej
Źródło:: Breast disease [Breast Dis] 2023; Vol. 42 (1), pp. 59-66.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/metabolism
Breast Neoplasms*/pathology
Machine Learning*
Ultrasonography*
Female ; Humans ; Pilot Projects ; Receptor, ErbB-2/metabolism ; Retrospective Studies ; Triple Negative Breast Neoplasms/diagnostic imaging ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""breast neoplasms"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język